W. Petersen

发表

A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease.

A. Brownlie, A. Zwinderman, M. Hayden, 2004, Journal of the American College of Cardiology.

Gene therapy for lipoprotein lipase deficiency: working toward clinical application.

M. Hayden, P. Dijkhuizen, J. Kastelein, 2005, Human gene therapy.

Novel ApoA-l Mutation ( L 178 P ) leads to endothelial dysfunction , increased arterial wall thickness and premature coronary artery disease

A. Zwinderman, M. Hayden, J. Kastelein, 2009 .

HDL and Coronary Artery Disease A Novel ApoA-I Mutation (L178P) Leads to Endothelial Dysfunction, Increased Arterial Wall Thickness, and Premature Coronary Artery Disease

A. Brownlie, A. Zwinderman, M. Hayden, 2004 .

Proinsulin, insulin, and C-peptide in cystic fibrosis after an oral glucose tolerance test.

C. Binder, C. Heilmann, K. Petersen, 1988, Diabetes research.

Pancreatic Enzyme Supplementation as Acid‐Resistant Microspheres versus Enteric‐Coated Granules in Cystic Fibrosis

C. Heilmann, S. Garne, W. Petersen, 1987, Acta paediatrica Scandinavica.

Compromised LCAT Function Is Associated With Increased Atherosclerosis

A. Zwinderman, J. Kastelein, A. Stalenhoef, 2005, Circulation.

Glucose Tolerance and Insulin Receptor Binding to Monocytes and Erythrocytes in Patients with Cystic Fibrosis

C. Heilmann, K. Petersen, C. Koch, 1988, Acta paediatrica Scandinavica.

UvA-DARE ( Digital Academic Repository ) High-density lipoprotein and C-reactive protein , friend and foe in cardiovascular disease

A. Zwinderman, J. Kuivenhoven, G. Hovingh, 2009 .